Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $0.6552W HIGH $2.05
Volume
25.21 K
Value Traded
65.89 K
Short % Float
1.99%
-1.84%Week
+4.2%1 Month
-15.51%3 Month
-19.29%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
7.78 M
EPS (TTM)
-0.89
P/E Ratio
-
Ent. Value
4.09 M
Total Shares
8.61 M
Float Shares
7.95 M
Insiders
8.72%
Institutions
8.27%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
LUCY Catalyst Timeline
Dated clinical, regulatory and corporate events for Innovative Eyewear, Inc. Common Stock
Past FDA Catalysts and PDUFA Decisions
How LUCY actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Innovative Eyewear, Inc. is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every LUCY program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Cohen David EricOfficer | Sell | 18,200 | $0.11 | 08/19/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in LUCY
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in LUCY for Q2 2026. | ||||
LUCY Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How LUCY ranks across every disease it competes in
Competitive Position is a premium feature
See how LUCY ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialLUCY News
-LUCY
Oct 8, 2026▼ -0.7%today
Innovative Eyewear, Inc. Launches Lucyd Aero
Innovative Eyewear, Inc. has launched the Lucyd Aero smart eyewear collection, which combines the lightweight design of traditional glasses with advanced AI features. The frames, weighing between 1-1.2 oz, are designed for comfort and everyday wear, featuring invisible touch controls and a privacy-first approach. Priced at $149, the collection aims to make smart eyewear more accessible to consumers.
Read more →-LUCY
Jul 8, 2026▼ -22.2%on this news
Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds
Innovative Eyewear, Inc. has announced the immediate exercise of warrants, resulting in approximately $3.0 million in gross proceeds. The exercise involves 2,200,544 shares at a reduced price of $1.35 per share. The company will also issue new Series J warrants, which could provide an additional $7.25 million if fully exercised. Proceeds will be used for working capital.
Read more →-LUCY
Jul 7, 2026Innovative Eyewear, Inc. Announces 345-Store Rollout with FYihealth Group
Innovative Eyewear, Inc. has announced a partnership with FYihealth group to launch Lucyd Armor® smart safety eyewear in 345 stores across Canada. This rollout marks the first national introduction of Lucyd products in the Canadian optical market, aiming to enhance accessibility and affordability for consumers. The initial product placement is set to begin in Q3 2026.
Read more →-LUCY
Jun 23, 2026▲ +6%on this newsshared move
Innovative Eyewear, Inc. Partners with Encore Optical Laboratory to Provide New Lens Technologies for Smart Eyewear
Innovative Eyewear, Inc. has partnered with Encore Optical Laboratory to enhance its smart eyewear offerings. This collaboration introduces advanced lens technologies, including Chemistrie lens clips and Zeiss PhotoFusion X lenses, which provide various functionalities and rapid tint changes. The partnership aims to expand prescription options for Lucyd Armor safety glasses, catering to a broader market.
Read more →-LUCY
Jan 7, 2026▲ +47.5%on this news
Innovative Eyewear, Inc. Announces Record-Breaking 65% Annual Sales Growth in 2025 & Insider Buying Intent
Innovative Eyewear, Inc. (LUCY) has announced a record-breaking 65% annual sales growth for 2025, with preliminary sales of approximately $2.7 million. The company attributes this growth to its smart eyewear portfolio and maintains a 44% market share in smart safety glasses on Amazon. Management is optimistic about future prospects, including planned share purchases by executives, which reflects their confidence in the company’s market position and growth strategy. The company expects to secure significant retail placements in 2026 as it continues to expand its distribution channels.
Read more →-LUCY
Jun 23, 2025▼ -29.5%on this news· ran to -42% by day 3
Innovative Eyewear, Inc. Announces $4.8 Million of Gross Proceeds Raised from Warrant Transactions
Innovative Eyewear, Inc. (LUCY) announced the successful raising of $4.8 million through warrant transactions, including $2.2 million from a warrant inducement transaction and $2.6 million from additional warrant exercises. The funds are expected to support working capital and general corporate purposes. This financial boost highlights investor confidence in the company's smart eyewear products. The company plans to file a registration statement with the SEC to cover the resale of shares associated with the newly issued warrants.
Read more →-LUCY
Apr 11, 2025▼ -52.5%on this news· ran to -63% by day 3
Innovative Eyewear, Inc. Announces Exercise of Warrants for $1.8 Million Gross Proceeds
Innovative Eyewear, Inc. has announced that it will exercise certain outstanding warrants, resulting in gross proceeds of $1.8 million. The warrants are being exercised at a reduced price of $2.60 per share, and the transaction is expected to close around April 14, 2025. The funds raised will primarily be used for working capital and general corporate purposes, while new warrants will also be issued during this process. H.C. Wainwright & Co. is serving as the exclusive placement agent for this offering.
Read more →-LUCY
Sep 25, 2024Innovative Eyewear, Inc. Adopts Limited Duration Stockholders Rights Plan MIAMI
Innovative Eyewear, Inc. has announced the adoption of a limited duration stockholders rights plan to protect the company's interests and its investors. This plan allows stockholders to receive rights for each outstanding share, which becomes exercisable if someone acquires 20% or more of the common stock without board approval. The rights plan is designed to prevent hostile takeovers and ensure that stockholders can maximize the value of their investments. It is set to expire on September 25, 2025, unless extended or modified by the board.
Read more →-LUCY
Sep 23, 2024▼ -16.1%on this newsshared move
Innovative Eyewear, Inc. Announces Exercise of Warrants for $2.6 Million Gross Proceeds MIAMI
Innovative Eyewear, Inc. announced the immediate exercise of certain warrants that will generate approximately $2.6 million in gross proceeds. The company plans to use the funds for working capital and general corporate purposes. Alongside this exercise, new Series E and Series F warrants will be issued. H.C. Wainwright & Co. is acting as the exclusive placement agent for this transaction, which is subject to customary closing conditions.
Read more →-LUCY
Sep 5, 2024Innovative Eyewear, Inc.
Innovative Eyewear, Inc. announced the immediate exercise of certain outstanding warrants, resulting in the issuance of 126,699 shares of common stock. The exercise is at a reduced price of $5.00 per share, significantly lower than the original price of $21.00. The total gross proceeds from this transaction are expected to be around $633,495. The company will use the funds for working capital and general corporate purposes. Additionally, new unregistered Series A and Series B warrants will also be issued as part of this agreement.
Read more →-LUCY
Jan 5, 2024▼ -6.8%on this news
Eyewear, Inc.
Innovative Eyewear, Inc. (NASDAQ: LUCY) has announced a new license agreement with IngenioSpec LLC, which covers multiple patents related to smart eyewear. This agreement is expected to enhance Innovative Eyewear's product offerings in the competitive smart eyewear marketplace. CEO Gross expressed optimism about the strategic advantage provided by this collaboration, considering the company's existing portfolio of over 60 patents. The development underscores Innovative Eyewear's commitment to innovation in the optical market.
Read more →-LUCY
Jun 22, 2023▼ -27.3%on this news
Innovative Eyewear Announces Pricing of $4.7 Million Public Offering MIAMI
Innovative Eyewear Inc. has announced the pricing of a public offering amounting to $4.7 million, involving 4,500,000 units priced at $1.05 each. Each unit consists of one share of common stock and one warrant for an additional share at the same price. The company plans to use the proceeds primarily for working capital and general corporate purposes. This offering is set to close on June 26, 2023, pending customary closing conditions.
Read more →-LUCY
Dec 28, 2022▲ +39%on this news
Innovative Eyewear Inc.
Innovative Eyewear Inc. Nasdaq: LUCY _________________________________ Investor Presentation - Dec. 2022 2022 Innovative Eyewear, Inc. IMPORTANT NOTICE This presentation contains "forward looking statements" within the meaning of Section 27 A of the Securities Act of 1933 as ame
Read more →About Innovative Eyewear, Inc. Common Stock
Headquarters11900 BISCAYNE BLVD, MIAMI, FL, 33181
BIOPHARMAWATCH ELITE PLUS
Trade the next LUCY catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime